Glanbia plc (OTCMKTS:GLAPF – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $25.76 and traded as high as $27.83. Glanbia shares last traded at $27.83, with a volume of 100 shares traded.
Analysts Set New Price Targets
A number of brokerages recently weighed in on GLAPF. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Glanbia in a research note on Friday, June 26th. Oddo Bhf downgraded Glanbia to a “neutral” rating in a research note on Wednesday. Finally, Barclays restated an “overweight” rating on shares of Glanbia in a report on Wednesday, June 17th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Report on GLAPF
Glanbia Stock Performance
About Glanbia
Glanbia plc is a global nutrition group headquartered in Kilkenny, Ireland, with roots tracing back to the merger of Avonmore and Waterford agricultural cooperatives in 1997. The company is organized around two main divisions: Performance Nutrition, which focuses on sports and lifestyle-forward consumer products, and Glanbia Nutritionals, which supplies nutritional ingredients and custom formulation services to food, beverage and pharmaceutical customers.
Under its Performance Nutrition arm, Glanbia markets well-known brands of protein powders, bars and ready-to-drink beverages designed for athletes, fitness enthusiasts and wellness-focused consumers.
Featured Stories
- Five stocks we like better than Glanbia
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
